| 000 | 01506 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250517052459.0 | ||
| 264 | 0 | _c20160211 | |
| 008 | 201602s 0 0 eng d | ||
| 022 | _a1526-632X | ||
| 024 | 7 |
_a10.1212/WNL.0000000000002035 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTurner, R Scott | |
| 245 | 0 | 0 |
_aA randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease. _h[electronic resource] |
| 260 |
_bNeurology _cOct 2015 |
||
| 300 |
_a1383-91 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S. | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAlzheimer Disease _xblood |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGastrointestinal Diseases _xblood |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aResveratrol |
| 650 | 0 | 4 |
_aStilbenes _xadverse effects |
| 700 | 1 | _aThomas, Ronald G | |
| 700 | 1 | _aCraft, Suzanne | |
| 700 | 1 | _avan Dyck, Christopher H | |
| 700 | 1 | _aMintzer, Jacobo | |
| 700 | 1 | _aReynolds, Brigid A | |
| 700 | 1 | _aBrewer, James B | |
| 700 | 1 | _aRissman, Robert A | |
| 700 | 1 | _aRaman, Rema | |
| 700 | 1 | _aAisen, Paul S | |
| 773 | 0 |
_tNeurology _gvol. 85 _gno. 16 _gp. 1383-91 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1212/WNL.0000000000002035 _zAvailable from publisher's website |
| 999 |
_c25253771 _d25253771 |
||